Showing results (1121-1130 of 1,963) with videos related to

Sort By:
Pageof 197
RMD Open|February 24, 2021
Digital rheumatology in the era of COVID-19: results of a national patient and physician surveyAnna Kernder, Harriet Morf, Philipp Klemm, et al.
RMD Open|February 9, 2017
Efficacy and safety of biological and targeted-synthetic DMARDs: a systematic literature review informing the 2016 update of the ASAS/EULAR recommendations for the management of axial spondyloarthritisAlexandre Sepriano, Andrea Regel, Désirée van der Heijde, et al.
RMD Open|March 4, 2017
DAS28-CRP and DAS28-ESR cut-offs for high disease activity in rheumatoid arthritis are not interchangeableRoy M Fleischmann, Désirée van der Heijde, Philip V Gardiner, et al.
RMD Open|December 10, 2016
Improving inflammatory arthritis management through tighter monitoring of patients and the use of innovative electronic toolsPiet van Riel, Rieke Alten, Bernard Combe, et al.
RMD Open|December 10, 2016
What is the reliability of non-trained investigators in recognising structural MRI lesions of sacroiliac joints in patients with recent inflammatory back pain? Results of the DESIR cohortCharlotte Jacquemin, Roxana Rubio Vargas, Rosaline van den Berg, et al.
RMD Open|December 10, 2016
Educational needs of health professionals working in rheumatology in EuropeTheodora P M Vliet Vlieland, Cornelia H M van den Ende, Francoise Alliot-Launois, et al.
RMD Open|December 10, 2016
Systematic review and quality analysis of emerging diagnostic measures for calcium pyrophosphate crystal deposition diseaseY Wu, K Chen, R Terkeltaub
RMD Open|January 12, 2017
Development of a feasible and responsive ultrasound inflammation score for rheumatoid arthritis through a data-driven approachAnna-Birgitte Aga, Hilde Berner Hammer, Inge Christoffer Olsen, et al.
RMD Open|April 14, 2017
Patient-reported outcomes from a phase III study of baricitinib in patients with conventional synthetic DMARD-refractory rheumatoid arthritisPaul Emery, Ricardo Blanco, Jose Maldonado Cocco, et al.
RMD Open|April 14, 2017
Modified-release prednisone for polymyalgia rheumatica: a multicentre, randomised, active-controlled, double-blind, parallel-group studyMaurizio Cutolo, Michael Hopp, Stefan Liebscher, et al.
Pageof 197